Furthering the commitment to strengthening delivery of global standards of clinical excellence, the CK Birla Hospital, recently treated a 59-year-old male patient for large thyroid swelling (goiter). The patient was suffering from thyroid swelling for many years and with time the entire right neck was affected, causing difficulty in neck movement. The patient had delayed the surgery for many years as he was apprehensive about the results and post-surgery complications.
In thyroid surgeries across the best centers in world there is approximately 25% chance of calcium derangement due to accidental removal or injury to parathyroid glands (which control calcium levels in the human body and lie very close to thyroid gland) & 8% chance of injury to voice nerve i.e. Recurrent Larangeal Nerve also positioned just below the thyroid gland.
Upon examination of the patient, Dr Mandeep Singh Malhotra, Director, Surgical Oncology, CK Birla Hospital, and his team recommended thyroidectomy treatment using NIFI and nerve monitoring. NIFI uses Infra red technology to identify and preserve the parathyroid glands during thyroid surgery. The use of NIFI offers significant benefits to patients by reducing the post thyroid surgery calcium derangement to <1%. The use of nerve monitor helps in identifying and preserving the voice nerve.
Commenting on the case, Dr Mandeep Singh Malhotra, Director, Surgical Oncology, CK Birla Hospital said, “This technology was earlier available from abroad thus making it an expensive treatment option; but it is now available in Delhi, India at the CK Birla Hospital, thus making treatment safer, accessible and affordable for Indian patients. A total of six thyroid surgeries have been performed using this advanced technology; three patients had thyroid cancer and three had large colloid goiters. All six patients had no calcium derangement post surgery.’
Near-infrared imaging is an effective technology for identifying the parathyroid gland during surgery. With its availability in India, better clinical outcomes can be offered to patients. Adoption of this technology by the CK Birla Hospital is a step towards the Make in India initiative by the Government of India.
Speaking on the occasion, Mr. Akshat Seth, Chief Executive Officer, CK Birla Healthcare, said, “We are committed to achieving our goal of providing global standards of healthcare by using advanced medical innovations and techniques for exceptional patient outcomes. The development of this medical technology in India is extremely helpful in saving lives. This case, like many others, is testimony to our legacy of delivering high-quality healthcare services.”
“Our centre at Delhi, Punjabi Bagh aims to take forward clinically reliable and patient-centric care that we stand for. The success of this case has been a milestone for us, reaffirming our state-of-the-art medical infrastructure and technology, clinical excellence, and our dedicated team of experts, said Mr. Vipul Jain, Chief Business Officer, CK Birla Hospital.